Nytt, dyrare medel mot ovarialcancer. Ar det värt sitt pris?
(1997) In Läkartidningen 94(1-2). p.4-21
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/42055ccb-8b1c-4ad6-a20f-220aa4881528
- author
- Högberg, T LU ; Karlsson, G ; Ridderheim, M LU ; Boman, K ; Frankendal, B ; Horvath, G ; Sorbe, B ; Strang, P and Rosenberg, P
- organization
- alternative title
- A new, more expensive agent against ovarian cancer. Worth its price?
- publishing date
- 1997-01-08
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Antineoplastic Agents, Phytogenic/economics, Cost of Illness, Cost-Benefit Analysis, Drug Costs, Female, Humans, Ovarian Neoplasms/drug therapy, Paclitaxel/economics, Quality of Life, Sweden
- in
- Läkartidningen
- volume
- 94
- issue
- 1-2
- pages
- 4 - 21
- publisher
- Swedish Medical Association
- external identifiers
-
- pmid:9053597
- scopus:18244419858
- ISSN
- 0023-7205
- language
- Swedish
- LU publication?
- yes
- id
- 42055ccb-8b1c-4ad6-a20f-220aa4881528
- alternative location
- https://www.lakartidningen.se/OldPdfFiles/1997/15018.pdf
- date added to LUP
- 2019-09-20 08:05:34
- date last changed
- 2024-04-30 22:05:24
@article{42055ccb-8b1c-4ad6-a20f-220aa4881528,
author = {{Högberg, T and Karlsson, G and Ridderheim, M and Boman, K and Frankendal, B and Horvath, G and Sorbe, B and Strang, P and Rosenberg, P}},
issn = {{0023-7205}},
keywords = {{Antineoplastic Agents, Phytogenic/economics; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Humans; Ovarian Neoplasms/drug therapy; Paclitaxel/economics; Quality of Life; Sweden}},
language = {{swe}},
month = {{01}},
number = {{1-2}},
pages = {{4--21}},
publisher = {{Swedish Medical Association}},
series = {{Läkartidningen}},
title = {{Nytt, dyrare medel mot ovarialcancer. Ar det värt sitt pris?}},
url = {{https://www.lakartidningen.se/OldPdfFiles/1997/15018.pdf}},
volume = {{94}},
year = {{1997}},
}